Literature DB >> 18629388

Hepatic lesion radiotherapy: a new option? Interview by Paul Adams.

Michael Lock.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18629388      PMCID： PMC2661264          DOI： 10.1155/2008/161538

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN： 0835-7900            Impact factor:   3.522


× No keyword cloud information.
  6 in total

1.  Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies.

Authors:  L A Dawson; C J McGinn; D Normolle; R K Ten Haken; S Walker; W Ensminger; T S Lawrence
Journal:  J Clin Oncol       Date:  2000-06       Impact factor: 44.544

2.  Local radiotherapy for unresectable hepatocellular carcinoma patients who failed with transcatheter arterial chemoembolization.

Authors:  J Seong; H C Park; K H Han; D Y Lee; J T Lee; C Y Chon; Y M Moon; C O Suh
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-07-15       Impact factor: 7.038

3.  A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases.

Authors:  Tracey E Schefter; Brian D Kavanagh; Robert D Timmerman; Higinia R Cardenes; Anna Baron; Laurie E Gaspar
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-08-01       Impact factor: 7.038

Review 4.  Radiation therapy for hepatocellular carcinoma: from palliation to cure.

Authors:  Maria A Hawkins; Laura A Dawson
Journal:  Cancer       Date:  2006-04-15       Impact factor: 6.860

5.  Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma.

Authors:  Regina V Tse; Maria Hawkins; Gina Lockwood; John J Kim; Bernard Cummings; Jennifer Knox; Morris Sherman; Laura A Dawson
Journal:  J Clin Oncol       Date:  2008-01-02       Impact factor: 44.544

6.  Radiation-induced hepatic toxicity after radiotherapy combined with chemotherapy for hepatocellular carcinoma.

Authors:  Su J Shim; Jinsil Seong; Ik J Lee; Kwang H Han; Chae Y Chon; Sang H Ahn
Journal:  Hepatol Res       Date:  2007-07-04       Impact factor: 4.288
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.